Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03752684
Other study ID # IRB-131212001
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date April 2, 2018
Est. completion date December 31, 2024

Study information

Verified date December 2023
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to assess the efficacy of ingesting a small amount of the harmless bacterium Oxalobacter formigenes in establishing residence in the guts of human subjects and to determine whether this influences the oxalate passed in urine of healthy volunteers.


Description:

Adults that are not colonized with O. formigenes, have no history of stone disease and are in good health as judged by their medical history, a complete metabolic profile of their serum, and ranges of ions that influence stone formation in two 24-hour urine collections, will be recruited from within the greater Birmingham area. Recruited subjects will be between the ages of 18 to 65 years and with a BMI >19 and <32. Subjects not colonized with O. formigenes will consume, firstly, a controlled diet containing 50 mg oxalate and 1000mg calcium (low oxalate/normal calcium diet), followed by a 250 mg oxalate/400mg calcium controlled diet (moderately high oxalate/low calcium diet), with at least a one week washout between each diet, and then repeat the same sequence of diets after colonization with O.formigenes Group 1 strain OxCC13. Controlled diets will be prepared in the Metabolic Kitchen of the UAB Clinical Research Unit (CRU). Sustainability of colonization will be determined over time. Loss of colonization will be confirmed by having the subject consume an oxalate-rich meal with subsequent testing for O. formigenes.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 23
Est. completion date December 31, 2024
Est. primary completion date April 27, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 65 Years
Eligibility Inclusion Criteria: - Good health as judged from a medical history and reported medications - Not colonized with O. formigenes Exclusion Criteria: - History of any hepatic, renal, bowel or endocrine disease or any other condition that may influence the absorption, transport or urinary excretion of ions, which will compromise the interpretation of results - colonized with O. formigenes - abnormal urine chemistries or blood metabolic profiles

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Low Oxalate Diet
Subjects will be instructed to ingest a controlled diet low in oxalate
Moderately high oxalate/low calcium diet
Subjects will be instructed to ingest a controlled diet moderately high in oxalate
Oxalobacter formigenes
Subjects will ingest live preparation of O. formigenes

Locations

Country Name City State
United States University of Alabama at Birmingham Birmingham Alabama

Sponsors (1)

Lead Sponsor Collaborator
University of Alabama at Birmingham

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Measurement of urinary oxalate by ion chromatography mass spectrometry 1st 24 hour urine collection, started 24 hours after initiation of controlled diet 1st 24 hour collection
Primary Measurement of urinary oxalate by ion chromatography mass spectrometry 48 hours post diet 2nd 24 hour collection
Primary Measurement of urinary oxalate by ion chromatography mass spectrometry 72 hours post diet 3rd 24 hour collection
Primary Measurement of urinary oxalate by ion chromatography mass spectrometry 96 hours post diet 4th 24 hour urine collection
Secondary Measurement of stool oxalate by ion chromatography mass spectrometry First bowel movement collected during days 2 through 4 of dietary control Stool collected 48-96 hours post diet
Secondary Measurement of stool oxalate by ion chromatography mass spectrometry Second bowel movement collected during days 2 through 4 of dietary control Stool collected 48-96 hours post diet
Secondary Measurement of stool oxalate by ion chromatography mass spectrometry Third bowel movement collected during days 2 through 4 of dietary control Stool collected 48-96 hours post diet
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04638166 - Mineral Water for Prevention of Renal Stones N/A
Not yet recruiting NCT04169165 - Patient Compliance for Metabolic Evaluation and Medical Management in Calcium Stone Patients
Recruiting NCT04669860 - Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma
Enrolling by invitation NCT01127854 - Pilot Study to Evaluate the Contribution of Gene Variants to Idiopathic Urolithiasis
Active, not recruiting NCT05081960 - Evaluating the Vitamin K2 Status of Calcium-based Stone Formers